← All Startups
Liberate Bio Seed
AI for genetic medicine
Liberate Bio develops non-viral delivery technologies for nucleic acid cargoes, aiming to address genetic disorders.
Location
Boston, Massachusetts, United States
Stage
Seed
Website
liberatebio.com
LinkedIn
View profile
BioinformaticsBiotechnologyGenetics
Founders
M
Michael Mitchell, PhD ’14
LinkedIn
News & Funding
2025-10-15 Seed Read article
Similar Startups
Centivax
Broad-spectrum vaccine
Stephanie Wisner ’16, ,
Celularity
Biotech cellular medicines
Robert Hariri, MD PhD ’87, ,
Ceribell Series C
Point-of-care EEG for seizure triage and treatment optimization
Xingjuan Chao, PhD ’05, ,
Freenome
Blood test to detect colorectal cancer
Gabriel Otte ’11, ,
Human Longevity Series B
Early detection for longer life
Robert Hariri, MD PhD ’87, ,
Moderna
mRNA vaccines
Robert Langer ’70, ,